ESC Premium Access

Antiplatelet therapy in PCI

Event: ESC Congress 2018
Topic: Cardiovascular Pharmacotherapy
Session type: Advances in Science
Date: 27 August 2018
Time: 11:00 - 12:30


5 presentations in this session

Antiplatelet therapy - State of the art

Speaker: Associate Professor B. Rocca (Rome, IT)

Newer P2Y12 inhibitors in a real-world setting: long-term outcomes from contemporary PCI with newer versus traditional dual antiplatelet regimes.

Speaker: Doctor M. Mohamed (Keele, GB)

Association of plasma concentration of trimethylamine N-oxide and ADP-induced platelet reactivity after a loading dose of clopidogrel 600 mg in patients undergoing elective PCI

Speaker: Professor D. Trenk (Freiburg, DE)

Meta-analysis of use of proton pump inhibitors with dual antiplatelet therapy after acute coronary syndrome

Speaker: Doctor E. Kaluski (Sayre, US)

The future of DAPT

Speaker: Professor R. Storey (Sheffield, GB)

5 speakers from this session

Associate Professor Bianca Rocca

Catholic University School of Medicine, Rome (Italy)
7 presentations
0 follower

Doctor Mohamed Mohamed

Keele University, Keele (United Kingdom of Great Britain & Northern Ireland)
0 follower

Professor Dietmar Trenk

University Medical Center Freiburg, Freiburg (Germany)
2 presentations
0 follower

Doctor Edo Kaluski

Guthrie Clinic, Sayre (United States of America)
0 follower

Professor Robert Storey

Department of Cardiovascular Science, University of Sheffield, Sheffield (United Kingdom of Great Britain & Northern Ireland)
17 presentations
1 follower

This platform is supported by

logo Novo Nordisk